scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...857324G |
P356 | DOI | 10.1371/JOURNAL.PONE.0057324 |
P932 | PMC publication ID | 3589474 |
P698 | PubMed publication ID | 23472081 |
P5875 | ResearchGate publication ID | 235886358 |
P50 | author | Julie Bossuyt | Q57401334 |
Donald M. Bers | Q40664240 | ||
Erhe Gao | Q38137327 | ||
P2093 | author name string | Linda Lee | |
Walter J Koch | |||
Douglas G Tilley | |||
Joseph E Rabinowitz | |||
J Kurt Chuprun | |||
Jonathan Hullmann | |||
Jeffrey S Martini | |||
Jessica I Gold | |||
P2860 | cites work | Structure-function analysis of G protein-coupled receptor kinase-5. Role of the carboxyl terminus in kinase regulation | Q22007990 |
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5 | Q24290618 | ||
G-protein-coupled receptor kinase 5 phosphorylates p53 and inhibits DNA damage-induced apoptosis | Q24298167 | ||
A predicted amphipathic helix mediates plasma membrane localization of GRK5 | Q24310352 | ||
Protein kinase cascades in the regulation of cardiac hypertrophy | Q24518494 | ||
Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine t | Q69789172 | ||
Regulation of G Protein-coupled Receptor Kinases by Calmodulin and Localization of the Calmodulin Binding Domain | Q73500683 | ||
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy | Q74469678 | ||
beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation | Q77452079 | ||
Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins | Q77747653 | ||
MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure | Q79922459 | ||
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial | Q84585426 | ||
Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases | Q38310327 | ||
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. | Q38322188 | ||
The effect of losartan and amlodipine on left ventricular diastolic function and atherosclerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study | Q38497180 | ||
Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions | Q39408797 | ||
G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression | Q39784124 | ||
G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence | Q40418854 | ||
Structure and mechanism of the G protein-coupled receptor kinases. | Q40774628 | ||
Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart | Q40892894 | ||
Phosphatidylinositol 4,5-bisphosphate (PIP2)-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies | Q41159622 | ||
Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling | Q41919774 | ||
Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C. | Q42062758 | ||
Characterization of lymphocyte beta 2-adrenoceptor signalling in patients with left ventricular volume overload disease | Q42518961 | ||
Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade | Q42538793 | ||
Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats | Q44019905 | ||
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial | Q44994661 | ||
Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. | Q45264881 | ||
Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5 | Q24561772 | ||
Activation of G Protein-Coupled Receptor Kinase 1 Involves Interactions between Its N-Terminal Region and Its Kinase Domain | Q27666718 | ||
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy | Q28219383 | ||
Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure | Q28568934 | ||
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development | Q28592216 | ||
Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2 | Q28611497 | ||
Inhibition of G protein-coupled receptor kinase subtypes by Ca2+/calmodulin | Q28646639 | ||
G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα. | Q33795250 | ||
Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins. | Q34100116 | ||
Regulation of G protein-coupled receptor kinases | Q34126348 | ||
Level of G protein–Coupled Receptor Kinase-2 Determines Myocardial Ischemia/Reperfusion Injury via Pro- and Anti-Apoptotic Mechanisms | Q34253155 | ||
Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease | Q34302311 | ||
Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases | Q34313936 | ||
Pathophysiological roles of G-protein-coupled receptor kinases | Q34418929 | ||
A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse | Q34423842 | ||
Dynamic changes in lymphocyte GRK2 levels in cardiac transplant patients: a biomarker for left ventricular function. | Q34479755 | ||
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials | Q34655367 | ||
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo | Q35159705 | ||
G protein-coupled receptor kinase 5 phosphorylation of hip regulates internalization of the chemokine receptor CXCR4 | Q35166206 | ||
Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure | Q35228115 | ||
Spatiotemporally distinct protein kinase D activation in adult cardiomyocytes in response to phenylephrine and endothelin | Q35312534 | ||
G Protein-coupled receptor kinase 5 is localized to centrosomes and regulates cell cycle progression | Q35838936 | ||
Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. | Q35951476 | ||
Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure | Q36286936 | ||
Physiological roles of G protein-coupled receptor kinases and arrestins | Q36737680 | ||
Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes | Q36858613 | ||
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha | Q36976809 | ||
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure | Q37000342 | ||
Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication | Q37118045 | ||
Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice | Q37369510 | ||
Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling. | Q37537689 | ||
G protein-coupled receptor kinases in normal and failing myocardium | Q37881660 | ||
A role for GRK2 in myocardial ischemic injury: indicators of a potential future therapy and diagnostic | Q37907329 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | G protein-coupled receptor | Q38173 |
P304 | page(s) | e57324 | |
P577 | publication date | 2013-03-05 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Nuclear translocation of cardiac G protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process | |
P478 | volume | 8 |
Q36679863 | "Canonical and non-canonical actions of GRK5 in the heart" |
Q38209177 | Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy |
Q28262711 | Atomic Structure of GRK5 Reveals Distinct Structural Features Novel for G Protein-coupled Receptor Kinases |
Q41684493 | Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy |
Q35978165 | Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor |
Q58698789 | Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease |
Q36780942 | Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy |
Q38871791 | Dual role of GRK5 in cancer development and progression |
Q47740257 | G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling. |
Q47910938 | G protein coupled-receptor signaling and reversible lysine acetylation |
Q34735239 | G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving β-blockers |
Q64228935 | GPCR Signaling Regulation: The Role of GRKs and Arrestins |
Q26851548 | GRK2 in the heart: a GPCR kinase and beyond |
Q60951267 | GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders |
Q34644069 | GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity |
Q35360619 | Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitor |
Q35054126 | Membrane orientation and binding determinants of G protein-coupled receptor kinase 5 as assessed by combined vibrational spectroscopic studies. |
Q35437365 | Modulation of angiotensin II signaling following exercise training in heart failure |
Q36651023 | Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases |
Q39193250 | Noncanonical Roles of G Protein-coupled Receptor Kinases in Cardiovascular Signaling |
Q57803947 | Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin |
Q34249070 | Overlapping and opposing functions of G protein-coupled receptor kinase 2 (GRK2) and GRK5 during heart development |
Q52599956 | PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) Regulates G-protein coupled Receptor Kinase 5 (GRK5) induced Cardiac Hypertrophy in vitro. |
Q92133355 | Perturbation of the interactions of calmodulin with GRK5 using a natural product chemical probe |
Q37388772 | Regulation of nuclear factor κB (NF-κB) in the nucleus of cardiomyocytes by G protein-coupled receptor kinase 5 (GRK5). |
Q37676935 | Structural insights into G protein-coupled receptor kinase function. |
Q47332344 | TRPV1 is a physiological regulator of μ-opioid receptors. |
Q36000382 | The evolving impact of g protein-coupled receptor kinases in cardiac health and disease |
Q30250314 | The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development |
Q42654068 | The influence of two functional genetic variants of GRK5 on tau phosphorylation and their association with Alzheimer's disease risk |
Q37697364 | Unveiling the membrane-binding properties of N-terminal and C-terminal regions of G protein-coupled receptor kinase 5 by combined optical spectroscopies |
Search more.